University of Sydney, Sydney, Australia.
University of Pennsylvania, Philadelphia, USA.
Monash Bioeth Rev. 2021 Jul;39(1):60-67. doi: 10.1007/s40592-021-00129-1. Epub 2021 May 25.
In recent years, bioethical discourse around the topic of 'genetic enhancement' has become increasingly politicized. We fear there is too much focus on the semantic question of whether we should call particular practices and emerging bio-technologies such as CRISPR 'eugenics', rather than the more important question of how we should view them from the perspective of ethics and policy. Here, we address the question of whether 'eugenics' can be defended and how proponents and critics of enhancement should engage with each other.
近年来，围绕“基因增强”这一主题的生物伦理讨论变得越来越政治化。我们担心人们过于关注某些特定实践和新兴生物技术（如 CRISPR）是否应被称为“优生学”的语义问题，而不是从伦理和政策角度看待它们的更重要问题。在这里，我们探讨了“优生学”是否可以被辩护以及增强的支持者和批评者应该如何相互交往的问题。
